Calamos Supports Greece

Eli Lilly pharmaceutical

New Alzheimer’s Drug Slows the Disease by a Third

A new Alzheimer's drug called Donanemab has shown promising results in slowing down the disease's progression, which is caused by a sticky substance called beta-amyloid that builds up in the brain. Donanemab works similarly to another drug called Lecanemab,...